Completed PHASE4 INTERVENTIONAL NCT00200941

Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS)

Sponsor: Neurocare

Conditions Restless Legs Syndrome

Interventions Topiramate

Updated 5 times since 2017 Last updated: Dec 15, 2005 Started: Aug 31, 2001 Completion: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Restless Legs Syndrome, this trial is completed. The trial is conducted by Neurocare and has accumulated 5 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neurocare
Ortho-McNeil Pharmaceutical

Data source: Neurocare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newton, United States